Viking Therapeutics(US:VKTX) Seeking Alpha·2025-10-04 13:44Core Viewpoint - Viking Therapeutics, Inc. (NASDAQ: VKTX) is positioned as a leading player in the GLP-1 weight-loss drug market, presenting a relatively de-risked investment opportunity [1]. Company Analysis - The company is focused on identifying reasonably priced firms with stable long-term growth prospects and small- to mid-cap companies that have the potential for exponential growth [1]. - Viking Therapeutics is involved in the development of GLP-1 drugs, which are gaining traction in the weight-loss sector, indicating a promising market position [1]. Investment Strategy - The analysis emphasizes the importance of fundamental analysis of businesses, financials, and valuations to uncover potential investment opportunities [1]. - The belief is that educated investors can outperform the market by understanding basic accounting and financial principles [1].